Confirm Journal Scope
Verify that the manuscript fits JDHAB’s scope in digital health, advanced biomaterials, biomedical technologies, imaging, artificial intelligence, clinical measurement, validation, or translational scientific workflows.
A practical guide for preparing complete, transparent, technically consistent, and submission-ready manuscripts for the Journal of Digital Health and Advanced Biomaterials — JDHAB.
This guide should be used together with the official JDHAB manuscript templates, the Instructions for Authors, the Article Types & Limits page, the Author Forms & Declarations, the Peer Review Process, and the journal’s Publication Ethics policy.
Authors remain responsible for the scientific accuracy, methodological transparency, ethical compliance, authorship information, references, tables, figures, declarations, and supplementary files included in the submission.
Prepare the manuscript directly in the official template corresponding to the selected article type.
Verify that the manuscript fits JDHAB’s scope in digital health, advanced biomaterials, biomedical technologies, imaging, artificial intelligence, clinical measurement, validation, or translational scientific workflows.
Choose the correct manuscript category and confirm its limits for word count, abstract length, figures, tables, supplementary material, and references.
Use the official template corresponding exactly to Original Research, Review Article, Methods and Validation, or Case Report / Case Series.
Insert the scientific content, metadata, declarations, references, tables, figures, captions, and supplementary information in the appropriate sections.
For Original Research, Review Articles, Methods and Validation articles, and Case Reports / Case Series, prepare a double-anonymized version derived from the same official template and remove identifying information.
Remove all instructional text and unused placeholders, verify consistency among files, and complete the final submission-readiness checklist.
Each article type has a distinct scientific structure. Authors should not use a generic Word document or adapt a template intended for another category.
For clinical, laboratory, observational, experimental, computational, diagnostic, and other original investigations.
For systematic, scoping, narrative, critical, integrative, and other evidence-synthesis manuscripts.
For methodological studies, validation studies, technical reports, software, protocols, reproducibility studies, and digital workflows.
For clinically relevant individual cases or case series with appropriate documentation, consent, analysis, and follow-up.
Manuscripts must be written in clear, formal, and scientifically precise English. Authors are responsible for linguistic accuracy, readability, and consistency of terminology.
Submit the identified manuscript and the blinded review manuscript as editable Microsoft Word files. A PDF must not be the only manuscript file.
Use A4 portrait pages and the single-column layout supplied in the appropriate official template. Do not rebuild the manuscript in a generic or two-column format.
Retain all required headings and sections. Optional sections may be removed only when they are not applicable to the study design or article type.
Remove all guidance, explanatory notes, examples, brackets, and unused placeholders before uploading the final manuscript files.
Define non-standard abbreviations at first use and apply them consistently. Use internationally recognized units, standardized scientific terminology, generic names, and accepted technical or taxonomic nomenclature.
Complete title-page information belongs in the identified manuscript and must not appear in the blinded review file.
Use a concise, informative, and scientifically accurate title. Identify the study design when this improves transparency or is required by the applicable reporting guideline.
Provide each author’s full name, academic degree, institutional affiliation, and ORCID iD. All authors must approve the authorship list and order before submission.
List the department, institution, city, state or region when applicable, and country. Use numbered affiliations when authors are associated with different institutions.
Provide the full name, a regularly monitored email address, and the complete postal address of the author responsible for editorial correspondence.
Follow the headings, organization, and maximum length specified in the selected article-type template. The abstract must accurately reflect the objective, methods, principal findings, and conclusion.
When applicable, report the principal numerical findings, effect estimates, precision measures, diagnostic performance, agreement indices, or relevant adverse outcomes.
The abstract conclusion must be directly supported by the reported findings and must not exaggerate causality, clinical relevance, superiority, or generalizability.
Provide 3 to 6 specific keywords that support discovery and indexing. Prefer recognized controlled vocabulary, including MeSH terminology when appropriate.
The exact headings and sequence vary by article type. Follow the official template; the elements below describe the principal scientific functions that must be addressed when applicable.
Define the scientific problem, summarize the relevant evidence, identify the unresolved gap, and end with a precise objective or research question.
Provide sufficient information for critical appraisal and, when applicable, independent reproduction. Describe the design, setting, participants or specimens, variables, procedures, outcomes, sample-size rationale, quality controls, and analysis.
Present findings in a logical sequence corresponding to the Methods. Report participant or specimen flow, missing data, numerical estimates, uncertainty, adverse events, and protocol deviations when applicable.
Interpret the principal findings in relation to the research question, existing evidence, strengths, limitations, clinical or technical implications, and future research.
Provide a concise answer to the stated objective. Avoid introducing new results or making claims that exceed the evidence presented.
Follow the applicable reporting guideline available through the EQUATOR Network and submit the completed checklist or flow diagram when required.
Tables must be editable, self-explanatory, consecutively numbered, and cited in the main text. Create them with the Word table tool; do not submit tables as screenshots or flattened images.
Use a concise title and define all abbreviations, statistical symbols, tests, units, and relevant explanatory information in the table notes.
Figures must be legible, consecutively numbered, cited in the text, and suitable for publication. Raster images should generally be at least 300 dpi, and separate publication-quality files must be supplied when requested.
Legends must allow independent interpretation and explain panels, symbols, abbreviations, measurement scales, annotations, and relevant image processing.
Remove unnecessary identifying information and obtain written consent for publication whenever a person may be recognized directly or indirectly.
Do not selectively enhance, delete, duplicate, obscure, or alter image content in a way that could misrepresent the original data. Any scientifically relevant processing must be applied consistently and disclosed.
References must follow Vancouver style according to the ICMJE Recommendations and the National Library of Medicine’s Citing Medicine.
Number references consecutively according to their first appearance and present in-text citations as Arabic superscript numerals. Reuse the original number when the same source is cited again.
Use official NLM journal abbreviations whenever available. Article titles should be presented in sentence case.
Include the DOI whenever available. Verify that every citation matches the reference list and that bibliographic details, links, corrections, and retraction status have been checked before submission.
State the approving institution, committee name, approval number, and relevant ethical framework, or explain why formal approval was not required.
State whether informed consent to participate was obtained when applicable. Provide a separate publication-consent statement when identifiable clinical information, images, recordings, or case details are included.
Applicable clinical trials must be registered prospectively in an accepted public registry. Report the registry, number, and date; include other study or review-protocol registration details when applicable.
Disclose all financial, professional, institutional, intellectual, or personal relationships that could influence, or reasonably appear to influence, the work.
Identify all funding sources, grant numbers, and the role of the funder in study design, analysis, interpretation, writing, or the decision to submit.
Describe individual contributions transparently using the CRediT taxonomy when appropriate. Artificial intelligence systems cannot be listed as authors.
State where supporting data, code, protocols, models, or analytical materials are available, preferably through a persistent repository, and specify any justified ethical, legal, or contractual access restrictions.
When relevant, identify the tool, version when known, purpose, stage, and extent of artificial intelligence-assisted or automated use. Authors must verify the output and remain fully responsible for accuracy, originality, confidentiality, and integrity.
The blinded manuscript must be an editable version derived from the same official template as the identified manuscript.
Remove author names, affiliations, email addresses, ORCID iDs, acknowledgments, author-contribution details, institutional identifiers, and other unnecessary information that could reveal authorship.
Retain the complete scientific structure, abstract, main text, references, tables, figures, captions, and non-identifying declarations. Replace identifying institutional details with neutral placeholders when necessary for anonymity.
Write self-citations in the third person and do not remove references that are scientifically necessary solely because they were authored by members of the submitting group.
Inspect document properties, tracked changes, comments, filenames, headers, footers, embedded metadata, and image information for identifying content before upload.
Complete editable Word document prepared with the appropriate official template, including title-page information and all applicable declarations.
Complete double-anonymized editable version derived from the same template and checked for identifying content.
Completed Author Declaration and License to Publish and Cover Letter; additional JDHAB forms must be included when applicable.
Separate publication-quality figures and supplementary files with consistent numbering and descriptive filenames when applicable.
Completed reporting checklist, flow diagram, and trial or protocol registration information when required.
JDHAB consent and third-party permission documentation when applicable. Retain original identifying records and provide them only through a secure process if requested.
The correct official template has been used and all article-type limits have been checked.
Title-page information, manuscript sections, metadata, declarations, tables, figures, and references are complete.
The review file preserves necessary scientific content and contains no avoidable identifying information or metadata.
Author forms, figures, supplements, checklists, permissions, and applicable consent documentation are ready.
Citations, references, numerical results, tables, figures, data statements, and registration details have been checked for consistency and accuracy.
All authors have approved the submission, and applicable ethics, consent, disclosure, funding, authorship, and artificial-intelligence requirements are satisfied.
Select and download the official editable template corresponding to the intended article type.
Review the complete editorial, scientific, technical, ethical, formatting, and reporting requirements.
Confirm the accepted categories and the maximum technical allowances for each manuscript type.
Download the required author declaration, license, cover letter, consent, and permission documents.
Understand technical screening, double-anonymized review, author responsibilities, revisions, and editorial decisions.
Proceed to the submission portal only after completing the manuscript and final checklist.
A manuscript is ready for submission only when it uses the correct official JDHAB template, follows the selected article-type limits, includes both identified and properly blinded files, contains all required declarations and supporting documents, presents complete and verified references, and contains no instructional text or unused placeholders.
Last updated: 11 August 2026.